Navigation Links
Lilly Confirms Date and Conference Call for First-Quarter 2012 Financial Results Announcement
Date:4/11/2012

INDIANAPOLIS, April 11, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2012 on Wednesday, April 25, 2012.  Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT.  Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at www.lilly.com. A replay will also be available on the website following the conference call.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015 Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" ... Jin Dongtao, chairman and executive director purchased 40,000,000 ordinary ... the existing entire issued share capital of the Company ... the total amount of approximately HK$113 million. Upon the ... increase from 45.17% to 47.17%. Mr. ...
(Date:4/1/2015)... 30, 2015 Research and Markets ( ... "An Introduction to the Medical Device Directives" conference ... detailed introduction to the European medical device legislation. It ... the involvement of Notified Bodies, how to choose one ... also cover the documentation necessary to apply for the ...
(Date:4/1/2015)... 2015  Philips Respironics, a division of Royal Philips ... Pico nasal mask is now available in ... obstructive sleep apnea (OSA). Designed to maximize comfort and effectiveness, ... pressure (CPAP) mask available on the market to treat OSA*. ... will be on display at Medtrade Spring (Booth ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3
... by FDA for long-term maintenance,treatment of COPD ... improved lung function,comparable to dry powder formoterol, ... profile --, NAPA, Calif., May 20, 2007 ... of the American Thoracic Society (ATS),demonstrate that ...
... Also Show Nebivolol Lowers Blood Pressure in ... 2007 /PRNewswire-FirstCall/ -- Forest,Laboratories, Inc. today presented ... pooled analysis of nebivolol, a selective beta,1-blocker ... U.S. Food and Drug Administration (FDA) for ...
Cached Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4
(Date:4/1/2015)... (PRWEB) April 01, 2015 NTOCC today ... transitions of care tools that seek to improve care ... this program, NTOCC hopes to bring light to tools ... transitions of care across the healthcare industry through the ... that advance collaborative patient-care. Following that vision, the Knowledge ...
(Date:4/1/2015)... panel session will look at the need for insurance ... that can grow in a privacy-friendly manner, thus preventing ... This topic has taken on even greater relevance in ... aren’t as secure as the automobile industry thought they ... Snapshot dongles contained very significant security flaws, which allowed ...
(Date:4/1/2015)... 2015 After a particularly harsh winter, many ... can lead to costly damage, so Amica Insurance ... sharing the following suggestions from AAA: , , ... be inflated to the manufacturer’s recommended levels. , ... vibration and uneven tire wear can be signs of bad ...
(Date:4/1/2015)... Baby Bellies & Beyond Baby Expo, ... on the top products and services to new and ... Records title for "Mommy Moments” - the largest gathering ... Baby Bellies & Beyond Expo Orlando on Sunday, April ... Record will commence at 11:00am with actual record counting ...
(Date:4/1/2015)... 2015 The Pennsylvania Court overseeing a ... http://www.risperdallawsuit2014.com/ ) has scheduled a meeting for April ... Court of Common Pleas, the meeting will commence at ... records indicate that the proceeding will address the progress ... users who experienced gynecomastia (male breast growth) and other ...
Breaking Medicine News(10 mins):Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 2Health News:TU-Automotive: Office of The Privacy Commissioner of Canada To Set Out Privacy Considerations Surrounding UBI Products 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3
... CHERRY HILL, N.J., April 9 Nuvilex, Inc. ... healthcare consumer products company with a portfolio of ... that Charleston Kentrist 41 Direct, Inc. (CK41), the ... four-step acne treatment system, intends to commence sales ...
... Featuring US experts in topical dermatological drug developmentPETALUMA, ... today announced that it will hold a 1-day ... USA" June 4, 2009 at the Hilton East ... the unique problems and issues confronted during development ...
... Inc. (Nasdaq: GXDX ), a provider of personalized ... financial results for the first quarter of 2009 after closing ... A conference call hosted by President and CEO, Dr. Tina ... place on the same day at 2:00pm PDT (5:00pm EDT) ...
... MONICA, Calif., April 9 Cord Blood America, Inc. ... cell preservation company ( http://www.cordblood-america.com ... stem cells to families nationwide and internationally, said that ... a sales operation, and completed their first sale in ...
... AUHC team led by Dr. Andrew Lasser, DPh, created the operational ... organized a steering committee of prominent Turkish academic physicians and led ... strategic vision for the new Anadolu Health Center. , ... ...
... brain infection , , WEDNESDAY, April 8 (HealthDay News) -- ... the U.S. market, California-based drug maker Genentech announced Wednesday. ... U.S. health officials issued a public health advisory on ... sometimes fatal brain infection. , In a prepared release, ...
Cached Medicine News:Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5Health News:Genoptix, Inc. to Announce First Quarter 2009 Financial Results 2Health News:Cord Blood America Announces First Storage Sale in Germany; Commitment to Expansion 2Health News:Anadolu Health Center 10 Year Award Review 2Health News:Anadolu Health Center 10 Year Award Review 3Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 2Health News:Psoriasis Drug Raptiva Pulled From U.S. Market 3
... important part in achieving an optimal ... capsule formation, inflammation and suture hole ... a nonabsorbable, ePTFE suture, delivers the ... a variety of surgical specialties. Soft, ...
... or creation of a vascular access, a ... of the utmost importance in many vascular ... those seeking a high-precision tunneling instrument. The ... of twisting or kinking for more accurate ...
... Cardiovascular Patch utilizes advanced fluoropolymer ... around penetrating suture and decrease ... much as 88 percent. This ... retention, multi-directional strength and low ...
... Grafts have met the challenges of ... for exceptional performance and quality, they ... surgeons worldwide. These grafts require no ... of infection, and ensure utmost thrombectomy ...
Medicine Products: